SYRE Live signaler | Maksimer profitt med Getagraph.com

KJøP 120171 min ago

@ $22.52

Utstedt: 14 feb 2024 @ 21:56

Avkastning: 52.04%

Forrige signal: feb 14 - 15:38

Forrige signal: Selg

Avkastning: -2.04 %

Live Chart Being Loaded With Signals

Commentary (7 mai 2024 @ 22:00):

Stats
Dagens volum	178 051
Gjennomsnittsvolum	508 649
Markedsverdi	1.25B
EPS	$-3.43 ( 2023-11-09 )
Neste inntjeningsdato	( $-0.900 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.0910 (0.27%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-25	Fairmount Funds Management Llc	Buy	3 639 680	Common Stock
2024-04-25	Fairmount Funds Management Llc	Sell	90 992	Series A Preferred Stock
2024-02-15	Turtle Cameron	Buy	400	Common Stock
2024-02-01	Mckenna Mark C.	Buy	40 000	Stock Option (Right to Buy)
2024-02-01	Mckenna Mark C.	Sell	477 000	Stock Option (Right to Buy)

INSIDER POWER
12.77
Last 11 transactions
Buy: 4 513 535 \| Sell: 4 003 472

Volum Korrelasjon

Lang: 0.04 (neutral)

Kort: 0.77 (moderate)

Signal:(43.052) Neutral

Spyre Therapeutics, Inc. Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Spyre Therapeutics, Inc. Korrelasjon - Valuta/Råvare

0.66
( moderate )

0.61
( weak )

0.56
( weak )

0.38
( neutral )

0.06
( neutral )

Spyre Therapeutics, Inc. Økonomi

Annual	2023
Omsetning:	$886 000
Bruttogevinst:	$-78 000.00 (-8.80 %)
EPS:	$-49.12

FY	2023
Omsetning:	$886 000
Bruttogevinst:	$-78 000.00 (-8.80 %)
EPS:	$-49.12

Financial Reports:

No articles found.

Spyre Therapeutics, Inc.

Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. The company's pipeline includes extended half-life antibodies targeting a4ß7, TL1A, and IL-23. The company was formerly known as Aeglea BioTherapeutics, Inc. and changed its name to Spyre Therapeutics, Inc. in November 2023. Spyre Therapeutics, Inc. was founded in 2013 and is based in Waltham, Massachusetts.

Sanntidsoppdatering for Spyre Therapeutics, Inc. [SYRE]

Upcoming Earnings Alert